Concepedia
PubMed · 2014 · 10 citations · 16 references
Open access
The combination of anti-angiogenic injections and PDT appears to be a safe and effective option for myopic CNV treatment and allows for a significant reduction of intravitreal injections.
16
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin
Ophthalmology · 2001 · 546 citations · Full text
Ocular Disease, Ophthalmology, Pathologic Myopia +7
Intravitreal Bevacizumab for Choroidal Neovascularization Attributable to Pathological Myopia: One-Year Results
Yasushi Ikuno, Kaori Sayanagi, Kaori Soga et al. · American Journal of Ophthalmology · 2008 · 165 citations
Choroidal Neovascularization Attributable, Ocular Disease, Vitreous Body +7
Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia
Izumi Yamamoto, Adam H. Rogers, Elias Reichel et al. · British Journal of Ophthalmology · 2006 · 147 citations · Full text
Intravitreal Bevacizumab Treatment for Choroidal Neovascularization in Pathologic Myopia: 12-month Results
Magda Gharbiya, Francesca Allievi, Luigi Mazzeo et al. · American Journal of Ophthalmology · 2008 · 116 citations
Ocular Disease, Vitreous Body, Ophthalmology +7
Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization
Timothy Y. Y. Lai, Franklin Luk, G K Y Lee et al. · Eye · 2012 · 101 citations · Full text
Ocular Disease, Angiogenesis, Primary Treatment +7